The global disposable medical device market is set to expand from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, ...
FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.
Q3 reported revenue of $138.7 million was comparable to last year and organic* revenue advanced 8% Third quarter GAAP earnings of $0.05 per ...
Stocktwits on MSN
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing
Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market ...
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to ...
CDSCO updates list of Class A non-sterile and non-measuring devices: Gireesh Babu, New Delhi Tuesday, November 4, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Organisa ...
The report 'Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain ...
announced that the U.S. Food and Drug Administration (FDA) has cleared expanded indications and upgraded features for its ...
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback